ARS is caused by a critical exposure to radiation, acute radiation syndrome
includes neutropenia, nervous system damage, and pneumonia with high fatality rate.
The product recently reported positive data from studies of PLX-R18 cells as a treatment for Acute Radiation Syndrome
conducted by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH), US Department of Health and Human Services (DHHS).
has been awarded additional federal funding for the development of a first-in-class, allogeneic, cell-based therapy (CLT-008) for the treatment of acute radiation syndrome
Department of Defense (DoD) to develop BIO 300 as a new medical radiation countermeasure (MRC) for lethal exposure to radiation, also known as Acute Radiation Syndrome
Net proceeds may be used by the company for general corporate, working capital purposes, the development of AEOL10150 as a medical countermeasure for the pulmonary effects of acute radiation syndrome
, to pursue human clinical trials with AEOL 10150 in Idiopathic Pulmonary Fibrosis and radiation oncology as well as the completion of pre-clinical development of AEOL 20415 for infectious diseases and AEOL 11114B for Parkinson's disease.
Contract Awarded for the advanced preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) as a MCM for the treatment of gastrointestinal acute radiation syndrome
TASE: PLTR) said that animal studies it has conducted suggest that its PLacental eXpanded (PLX) cells are potentially effective in treating life threatening hematopoietic complications associated with acute radiation syndrome
4 million under an option exercised by the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, for the advanced development of CLT-008, a first-in-class, allogeneic, cell-based therapy for the treatment of Acute Radiation Syndrome
Soligenix' vaccines/biodefense business segment includes active development programs for RiVax, its ricin toxin vaccine candidate; OrbeShield, a GI acute radiation syndrome
therapeutic candidate; and SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease.
M2 EQUITYBITES-June 29, 2015-Aeolus Pharmaceuticals reports Barda's exercises of USD3m in additional contract funding for development of AEOL 10150 for Acute Radiation Syndrome
M2 PHARMA-August 3, 2017-Bolder BioTechnology Begins Clinical Trial of BBT-015 for Treating Neutropenia and Acute Radiation Syndrome
Biotechnology company Aeolus Pharmaceuticals Inc (OTCQB:AOLS) revealed on Thursday the receipt of notice for AEOL 10150 for use in patients exposed to radiation following a nuclear accident or detonation in order to treat or mitigate acute radiation syndrome
will also be presenting Poster #1144 titled "Ex vivo-Generated Mouse Myeloid Progenitor Cells Mitigate Gastrointestinal Acute Radiation Syndrome
when Administered up to 5 Days after Irradiation.
The agreement is specifically funded by the National Institute of Allergy and Infectious Diseases and will support the development of OrbeShield as a medical countermeasure for the treatment of gastrointestinal acute radiation syndrome
The study, published on May 4, 2012 in the scientific journal, Radiation Research, represents the first report of an effective radiation countermeasure for Acute Radiation Syndrome
(ARS) across a broad range of lethal radiation doses when administered as late as seven (7) days after irradiation.